Evidence supporting the use of: Naphthoquinones
For the health condition: Leprosy

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 4

Naphthoquinones, particularly the compound clofazimine, have a well-established scientific basis for use in the treatment of leprosy (Hansen's disease). Clofazimine is a riminophenazine dye with a naphthoquinone structure, which was originally synthesized in the 1950s and found to have significant antimycobacterial activity. Scientific evaluation demonstrated its efficacy against Mycobacterium leprae, the causative organism of leprosy. Since the 1970s, clofazimine has been included as a key component of the World Health Organization's recommended multidrug therapy (MDT) for leprosy, alongside dapsone and rifampicin. Clinical studies and decades of use have shown that clofazimine is effective in reducing the bacterial load, preventing resistance, and managing leprosy reactions, particularly erythema nodosum leprosum (ENL), a complication of the disease. Its anti-inflammatory and immunomodulatory properties further support its therapeutic role. While other naphthoquinones are not widely used for leprosy, clofazimine's inclusion in international treatment guidelines and the substantial clinical data supporting its use provide a strong scientific rationale, reflected in its high evidence rating. Reports and clinical guidelines from the WHO, as well as peer-reviewed studies, confirm its safety and efficacy profile for this indication.

More about Naphthoquinones
More about Leprosy

Products containing Naphthoquinones

We currently have no products on Vitabase that contain this ingredient.